F2RL3

Jump to: navigation, search


Coagulation factor II (thrombin) receptor-like 3
Identifiers
Symbol(s) F2RL3; PAR4
External IDs OMIM: 602779 MGI1298207 Homologene36148
RNA expression pattern

PBB GE F2RL3 207221 at tn.png

More reference expression data

Orthologs
Human Mouse
Entrez 9002 14065
Ensembl ENSG00000127533 ENSMUSG00000050147
Uniprot Q96RI0 Q0VDX1
Refseq NM_003950 (mRNA)
NP_003941 (protein)
NM_007975 (mRNA)
NP_032001 (protein)
Location Chr 19: 16.86 - 16.87 Mb Chr 8: 75.66 - 75.66 Mb
Pubmed search [1] [2]

Coagulation factor II (thrombin) receptor-like 3, also known as F2RL3 or protease activated receptor 4 (PAR4), is a human gene.[1]


Coagulation factor II (thrombin) receptor-like 3 (F2RL3) is a member of the large family of 7-transmembrane-region receptors that couple to guanosine-nucleotide-binding proteins. F2RL3 is also a member of the protease-activated receptor family. F2RL3 is activated by proteolytic cleavage of its extracellular amino terminus. The new amino terminus functions as a tethered ligand and activates the receptor. F2RL3 is activated by thrombin and trypsin.[1]


See also

References

Further reading

  • Leger AJ, Covic L, Kuliopulos A (2006). "Protease-activated receptors in cardiovascular diseases.". Circulation 114 (10): 1070-7. doi:10.1161/CIRCULATIONAHA.105.574830. PMID 16952995.
  • Xu WF, Andersen H, Whitmore TE, et al. (1998). "Cloning and characterization of human protease-activated receptor 4.". Proc. Natl. Acad. Sci. U.S.A. 95 (12): 6642-6. PMID 9618465.
  • Kahn ML, Zheng YW, Huang W, et al. (1998). "A dual thrombin receptor system for platelet activation.". Nature 394 (6694): 690-4. doi:10.1038/29325. PMID 9716134.
  • Kahn ML, Hammes SR, Botka C, Coughlin SR (1998). "Gene and locus structure and chromosomal localization of the protease-activated receptor gene family.". J. Biol. Chem. 273 (36): 23290-6. PMID 9722561.
  • Kahn ML, Nakanishi-Matsui M, Shapiro MJ, et al. (1999). "Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.". J. Clin. Invest. 103 (6): 879-87. PMID 10079109.
  • Andersen H, Greenberg DL, Fujikawa K, et al. (1999). "Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity.". Proc. Natl. Acad. Sci. U.S.A. 96 (20): 11189-93. PMID 10500152.
  • Page G, Kögel D, Rangnekar V, Scheidtmann KH (2000). "Interaction partners of Dlk/ZIP kinase: co-expression of Dlk/ZIP kinase and Par-4 results in cytoplasmic retention and apoptosis.". Oncogene 18 (51): 7265-73. doi:10.1038/sj.onc.1203170. PMID 10602480.
  • Sambrano GR, Huang W, Faruqi T, et al. (2000). "Cathepsin G activates protease-activated receptor-4 in human platelets.". J. Biol. Chem. 275 (10): 6819-23. PMID 10702240.
  • Nakanishi-Matsui M, Zheng YW, Sulciner DJ, et al. (2000). "PAR3 is a cofactor for PAR4 activation by thrombin.". Nature 404 (6778): 609-13. doi:10.1038/35007085. PMID 10766244.
  • Miike S, McWilliam AS, Kita H (2002). "Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.". J. Immunol. 167 (11): 6615-22. PMID 11714832.
  • Asokananthan N, Graham PT, Fink J, et al. (2002). "Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells.". J. Immunol. 168 (7): 3577-85. PMID 11907122.
  • Henriksen RA, Hanks VK (2002). "PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets.". Arterioscler. Thromb. Vasc. Biol. 22 (5): 861-6. PMID 12006403.
  • Covic L, Singh C, Smith H, Kuliopulos A (2003). "Role of the PAR4 thrombin receptor in stabilizing platelet-platelet aggregates as revealed by a patient with Hermansky-Pudlak syndrome.". Thromb. Haemost. 87 (4): 722-7. PMID 12008957.
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Owen WG (2003). "PAR-3 is a low-affinity substrate, high affinity effector of thrombin.". Biochem. Biophys. Res. Commun. 305 (1): 166-8. PMID 12732212.
  • Adam F, Verbeuren TJ, Fauchère JL, et al. (2003). "Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP.". J. Thromb. Haemost. 1 (4): 798-804. PMID 12871418.
  • Wu CC, Hwang TL, Liao CH, et al. (2004). "The role of PAR4 in thrombin-induced thromboxane production in human platelets.". Thromb. Haemost. 90 (2): 299-308. doi:10.1267/THRO03020299. PMID 12888878.
  • Kawai T, Akira S, Reed JC (2003). "ZIP kinase triggers apoptosis from nuclear PML oncogenic domains.". Mol. Cell. Biol. 23 (17): 6174-86. PMID 12917339.
  • Jacques SL, Kuliopulos A (2004). "Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage.". Biochem. J. 376 (Pt 3): 733-40. doi:10.1042/BJ20030954. PMID 13678420.
  • Han Y, Nurden A, Combrié R, Pasquet JM (2004). "Redistribution of glycoprotein Ib within platelets in response to protease-activated receptors 1 and 4: roles of cytoskeleton and calcium.". J. Thromb. Haemost. 1 (10): 2206-15. PMID 14521606.

This article incorporates text from the United States National Library of Medicine, which is in the public domain. Template:Membrane-protein-stub


Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox